Glucose degradation products and peritoneal membrane function

被引:0
|
作者
Witowski, J
Bender, TO
Gahl, GM
Frei, U
Jörres, A
机构
[1] Humboldt Univ, Fak Med, Univ Klinikum Charite, Dept Nephrol & Med Intens Care, D-13353 Berlin, Germany
[2] Univ Poznan, Sch Med, Dept Pathophysiol, Poznan, Poland
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2001年 / 21卷 / 02期
关键词
glucose degradation products; bioincompatibility; peritoneal dialysis fluids; peritoneal mesothelium;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background:The bioincompatibility of peritoneal dialysis fluids (PDF) in current use has been partially attributed to the presence of glucose degradation products (GDPs), which are generated during heat sterilization of PDF. Several of the GDPs have been identified and we have recently demonstrated that these GDPs per se may impair the viability and function of human peritoneal mesothelial cells (HPMC) in vitro. It is also possible that GDP-related toxicity is further exacerbated by the milieu of PDF. We review the current literature on GDP and present the results of experiments comparing the impact of heat- and filter-sterilized PDF on the viability and function of HPMC. Methods: Peritoneal dialysis fluids with low (1.5%) and high (4.25%) glucose concentrations were laboratory prepared according to the standard formula and sterilized either by heat (H-PDF; 121 degreesC, 0.2 MPa, 20 minutes) or filtration (F-PDF; 0.2 mu). The buildup of GDP was confirmed by UV absorbance at 284 nm. Confluent HPMC monolayers were exposed to these solutions mixed 1:1 with standard M199 culture medium. After 24 hours, cell viability was assessed with the MTT assay, and interleukin-1 beta -stimulated monocyte chemotactic protein-1 (MCP-1) release with specific immunoassay. Results: Exposure of HPMC to H-PDF resulted in a significant decrease in cell viability, with solutions containing 4.25% glucose being more toxic than 1.5% glucose-based PDF (27.4% +/- 3.4% and 53.4% +/- 11.0% of control values, respectively). In contrast, viability of HPMC exposed to F-PDF was not different from that of control cells. Moreover, treatment with H-PDF impaired the release of MCP-1 from HPMC to a significantly greater degree compared to F-PDF (17.4% and 24.9% difference for low and high glucose PDF, respectively). Conclusions: Exposure of HPMC to H-PDF significantly impairs cell viability and the capacity for generating MCP-1 compared to F-PDF. This effect is likely to be mediated by GDPs present in H-PDF but not in F-PDF.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [21] Glucose degradation products in peritoneal dialysis fluids: How they can be avoided
    Wieslander, A
    Linden, T
    Kjellstrand, P
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S119 - S124
  • [22] The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial
    Johnson, David W.
    Brown, Fiona G.
    Clarke, Margaret
    Boudville, Neil
    Elias, Tony J.
    Foo, Marjorie W. Y.
    Jones, Bernard
    Kulkarni, Hemant
    Langham, Robyn
    Ranganathan, Dwarakanathan
    Schollum, John
    Suranyi, Michael G.
    Tan, Seng H.
    Voss, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (12) : 4445 - 4453
  • [23] A PERITONEAL DIALYSIS REGIMEN LOW IN GLUCOSE AND GLUCOSE DEGRADATION PRODUCTS RESULTS IN INCREASED CANCER ANTIGEN 125 AND PERITONEAL ACTIVATION
    le Poole, Caatje Y.
    Welten, Angelique G. A.
    ter Wee, Piet M.
    Paauw, Nanne J.
    Djorai, Amina N.
    Valentijn, Rob M.
    Beelen, Robert H. J.
    van den Born, Jacob
    van Ittersum, Frans J.
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (03): : 305 - 315
  • [24] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products (vol 13, pg 480, 2002)
    Mortier
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1419 - 1421
  • [25] Peritoneal dialysis solutions low in glucose degradation products evidence for clinical benefits
    Tomo, Tadashi
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 : S123 - S127
  • [26] Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se
    Witowski, J
    Bender, TO
    Wisniewska-Elnur, J
    Ksiazek, K
    Passlick-Deetjen, J
    Breborowicz, A
    Jörres, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2003, 23 (04): : 381 - 390
  • [27] The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
    Lin, Chih-Ching
    Niu, Chih-Yuan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 333 - 333
  • [28] Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model
    Kim, Chan-Duck
    Kwon, Hyeog-Man
    Park, Sun-Hee
    Oh, Eun-Joo
    Kim, Mi-Hyung
    Choi, Soon-Youn
    Choi, Min-Jeong
    Kim, In-San
    Park, Min-Sun
    Kim, Yong-Jin
    Kim, Yong-Lim
    THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (01) : 56 - 64
  • [29] The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
    Chang, Chia-Ning
    Niu, Chih-Yuan
    Tan, Ann Charis
    Chan, Chia-Hao
    Chen, Chun-Fan
    Chen, Tz-Heng
    Li, Szu-Yuan
    Chen, Yung-Tai
    Chen, Fan-Yu
    Li, Wen-Sheng
    Lin, Chih-Ching
    Wei, Guor-Jien
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [30] Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis
    Tauer, A
    Bender, TO
    Fleischmann, EH
    Niwa, T
    Jörres, A
    Pischetsrieder, M
    MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (07) : 710 - 715